background
detect
viral
respiratori
tract
infect
evolv
greatli
develop
pcr
base
commerci
system
capabl
simultan
detect
wide
varieti
pathogen
object
evalu
rel
perform
two
commerci
broad
rang
system
detect
viral
agent
clinic
respiratori
tract
specimen
immunocompromis
children
studi
design
total
patient
sampl
includ
analysi
repres
first
sampl
collect
patient
exclud
fail
reaction
sampl
deidentifi
assay
parallel
use
two
differ
broadli
multiplex
pcr
system
resplex
tm
ii
panel
resplex
qiagen
hilden
germani
filmarray
respiratori
panel
filmarray
idaho
technolog
inc
salt
lake
citi
ut
method
comparison
base
upon
pairwis
concord
result
accord
patient
age
viral
target
number
target
detect
result
two
system
show
overal
concord
patient
p
filmarray
detect
least
one
target
sampl
resplex
detect
least
one
target
resplex
fail
detect
filmarray
posit
filmarray
fail
detect
resplex
posit
rel
perform
system
includ
system
detect
higher
number
posit
sampl
vari
stratifi
target
viral
pathogen
conclus
broadli
multiplex
pcr
effect
mean
detect
larg
number
clinic
relev
respiratori
viral
pathogen
viral
respiratori
tract
infect
caus
seriou
morbid
increas
mortal
immunocompromis
pediatr
patient
rapid
sensit
detect
agent
implic
treatment
decis
clinic
care
infect
control
practic
area
diagnost
virolog
molecular
diagnost
method
shown
promis
markedli
improv
diagnost
sensit
compar
cultur
antigen
detect
assay
favor
perform
characterist
made
molecular
method
appeal
introduct
clinic
laboratori
slow
issu
relat
cost
technic
expertis
requir
perform
test
earli
version
test
focus
limit
number
pathogen
typic
detect
one
two
virus
group
virus
time
thu
detect
clinic
relev
entiti
requir
run
entir
panel
test
compound
cost
staf
requir
advent
broadli
multiplex
assay
sought
address
issu
frontend
multiplex
amplif
typic
pcr
follow
detect
capabl
identifi
differ
target
thu
singl
assay
util
sensit
pcr
mimic
diagnost
spectrum
cultur
creat
potenti
increas
routin
detect
beyond
cultiv
virus
reduc
process
cost
staf
requir
turnaround
time
technolog
also
offer
possibl
increas
abil
detect
multivir
infect
clinic
import
capabl
present
uncertain
may
carri
import
prognost
infect
control
relat
implic
particularli
among
immunocompromis
patient
studi
number
differ
methodolog
propos
market
use
approach
howev
limit
publish
studi
compar
differ
broadli
multiplex
system
oneanoth
current
studi
compar
two
system
panel
realtim
pcr
assay
target
individu
virus
technolog
evalu
includ
resplex
ii
panel
resplex
qiagen
hilden
germani
filmarray
respiratori
panel
filmarray
idaho
technolog
inc
salt
lake
citi
ut
product
use
studi
research
use
ruo
filmarray
product
recent
becom
avail
fdaclear
assay
time
submiss
studi
publish
examin
perform
method
use
clinic
respiratori
tract
specimen
two
broadli
multiplex
pcr
system
compar
panel
laboratori
develop
test
detect
respiratori
viral
pathogen
clinic
respiratori
tract
specimen
pediatr
immunocompromis
children
sampl
collect
prospect
part
routin
clinic
care
st
jude
children
research
hospit
sjcrh
januari
may
children
present
sign
symptom
upper
respiratori
tract
infect
result
patient
year
age
exclud
analysi
sjcrh
institut
review
board
irb
classifi
studi
nonhuman
research
studi
exempt
irb
approv
inform
consent
requir
waiv
sampl
consist
bronchoalveolar
lavag
bal
specimen
nasopharyng
swab
np
nasopharyng
wash
npw
tracheal
aspir
ta
unus
sampl
remain
routin
diagnost
test
deidentifi
blind
prior
studi
inclus
uniqu
patient
sampl
identifi
assign
sampl
order
match
result
obtain
variou
method
compar
sampl
divid
two
ml
aliquot
one
test
laboratori
develop
test
panel
ldtp
includ
pro
hmpv
assay
kit
genprob
san
diego
ca
detect
hmpv
sjrch
test
use
filmarray
assay
left
sampl
clinic
aliquot
test
resplexii
assay
diagnost
laboratori
servic
dl
aiea
hi
extract
perform
sjcrh
nucleic
acid
sent
store
frozen
dl
test
remot
site
collect
transport
storag
method
use
allow
preanalyt
standard
test
method
l
nucleic
acid
solut
extract
l
respiratori
sampl
togeth
prior
addit
rna
dna
control
ldtp
test
second
l
nucleic
acid
solut
extract
l
aliquot
respiratori
sampl
without
addit
rna
dna
control
respplexii
test
extract
otherwis
ident
perform
use
nuclisen
minimag
magnet
extract
system
inc
durham
nc
per
manufactur
instruct
rna
control
purchas
readytous
lyophil
beadcontain
kb
armor
synthet
nucleic
acid
cepheid
dna
control
plasmid
construct
insert
dna
fragment
phocid
herpesviru
type
gb
gene
vector
design
inhous
sjcrh
manufactur
genscript
corp
piscataway
nj
control
detect
ldtp
test
panel
realtim
pcr
assay
develop
detect
infa
infb
rsv
adenoviru
parainfluenza
virus
respiratori
specimen
pro
hmpv
assay
kit
also
run
part
panel
assay
util
taqman
chemistri
realtim
pcr
technolog
carri
smartcycl
ii
platform
cepheid
sunnyval
ca
molecular
detect
target
primer
probe
sequenc
list
tabl
resplex
tm
ii
panel
use
multiplex
rtpcr
analysi
amplifi
detect
respiratori
virus
filmarray
util
prefabr
pouch
contain
lyophil
reagent
sampl
ad
directli
pouch
wherein
specimen
prepar
amplif
detect
take
place
without
offlin
sampl
manipul
l
origin
sampl
mix
l
filmarray
lysi
buffer
approxim
ml
hydrat
solut
ad
syring
filmarray
pouch
hydrat
solut
inlet
port
l
samplelysi
buffer
mix
ad
pouch
sampl
inlet
port
pouch
load
filmarray
instrument
autom
extract
amplif
data
analysi
total
run
time
approxim
h
min
handson
time
qualiti
test
assur
inclus
two
rna
process
control
pc
pouch
proprietari
sequenc
idaho
technolog
rna
process
control
carri
stage
test
process
sampl
lysi
pcr
dna
melt
analysi
control
produc
posit
result
valid
test
result
filmarray
detect
viral
target
adenoviru
bocaviru
coronaviru
enteroviru
hmpv
human
rhinoviru
influenza
viru
type
b
parainfluenza
virus
rsv
mcnemar
test
use
compar
accuraci
three
test
comparison
made
pairwis
fashion
exact
method
use
discord
cell
less
observ
reduc
bia
first
sampl
patient
multipl
sampl
includ
analysi
purpos
analysi
patient
age
divid
four
differ
age
group
base
year
age
pair
studi
pairwis
comparison
made
perform
filmarray
resplex
filmarray
ldtp
resplex
ldtp
target
differ
system
comparison
result
collaps
narrowest
taxonom
categori
encompass
system
pair
result
individu
sampl
first
run
fail
exclud
analysi
howev
result
second
run
consecut
sampl
entir
run
fail
includ
analysi
assum
systemat
technologist
error
like
caus
failur
entir
run
resplex
system
posit
result
determin
use
cutoff
mean
fluoresc
intens
mfi
total
sampl
collect
children
studi
period
exclud
sampl
patient
age
sampl
obtain
first
collect
fail
run
total
number
sampl
analyz
singl
sampl
test
per
patient
failur
ldtp
total
number
fail
run
filmarray
resplex
mean
age
children
sampl
includ
analysi
year
rang
month
year
vast
major
sampl
npw
sampl
follow
ta
sampl
bal
sampl
one
np
test
sampl
came
children
younger
sampl
children
two
year
less
account
sampl
three
five
year
inclus
six
sampl
came
children
age
inclus
overal
differ
detect
target
filmarray
resplex
found
signific
p
sampl
detect
posit
filmarray
resplex
detect
target
sampl
filmarray
miss
sampl
detect
posit
resplex
tabl
total
number
sampl
system
agre
sampl
sampl
test
posit
sampl
test
neg
stratifi
differ
target
target
group
differ
observ
detect
coronaviru
exact
p
infa
exact
p
enteroviru
p
rhinoviru
p
analysi
stratifi
patient
age
show
age
sampl
posit
filmarray
resplex
miss
eight
sampl
p
likewis
age
group
sampl
posit
filmarray
resplex
miss
p
tabl
posit
result
stratifi
number
target
detect
filmarray
differ
detect
found
signific
case
filmarray
system
detect
one
two
target
tabl
case
filmarray
detect
one
target
resplex
detect
case
p
resplex
detect
target
six
sampl
sampl
filmarray
detect
presenc
two
target
p
six
sampl
target
detect
resplex
rhinoviru
coronaviru
rsv
adenoviru
bocaviru
coronaviru
enteroviru
analysi
comparison
includ
virus
target
system
target
group
adenoviru
hmpv
infa
parainfluenza
type
rsv
differ
number
posit
detect
either
system
either
overal
stratifi
target
tabl
differ
detect
rate
observ
data
stratifi
age
group
tabl
stratifi
number
target
detect
filmarray
ldtp
detect
virus
six
sampl
filmarray
call
neg
p
ldtp
detect
target
seven
sampl
filmarray
detect
one
target
p
tabl
percentag
sampl
detect
posit
resplex
lower
ldtp
among
sampl
detect
posit
resplex
ldtp
detect
resplex
detect
target
sampl
detect
posit
ldtp
p
target
group
signific
differ
observ
influenza
ldtp
detect
sampl
posit
influenza
resplex
detect
p
tabl
result
stratifi
age
group
signific
differ
observ
sampl
taken
children
age
tabl
resplex
detect
less
posit
compar
ldtp
sampl
children
age
less
remain
age
group
though
differ
signific
differ
detect
resplex
ldtp
signific
sampl
resplex
detect
target
tabl
introduct
multiplex
molecular
amplif
assay
detect
viral
respiratori
pathogen
improv
sensit
routin
viral
detect
method
rang
agent
detect
expand
includ
newli
discov
emerg
respiratori
virus
coronavirus
human
metapneumoviru
hmpv
bocaviru
broadli
multiplex
molecular
approach
studi
capabl
detect
identifi
virus
simultan
tradit
method
ie
cultur
dfa
show
increas
detect
rate
coinfect
current
studi
coinfect
detect
rang
similar
investig
sanghavi
et
al
investig
adult
pediatr
patient
includ
organ
transplant
found
dual
infect
tripl
studi
guittet
et
al
report
rang
hospit
children
clinic
signific
detect
one
viru
clear
calvo
et
al
report
multivir
infect
frequent
hospit
infant
respiratori
tract
diseas
infect
also
link
higher
fever
longer
hospit
stay
frequent
use
antibiot
singl
rsv
infect
anoth
studi
semper
et
al
coinfect
hmpv
rsv
reveal
tenfold
increas
rel
risk
admiss
pediatr
intensivecar
unit
mechan
ventil
result
sever
bronchiol
littl
publish
data
beyond
clinic
signific
multivir
respiratori
tract
infect
work
specif
import
detect
virus
find
suggest
broadli
multiplex
pcr
system
becom
common
new
bodi
literatur
need
develop
address
relev
implic
find
prognosi
treatment
infect
control
current
studi
knowledg
first
report
compar
filmarray
resplex
ii
direct
detect
viral
agent
clinic
respiratori
tract
specimen
immunocompromis
children
viral
target
two
system
similar
previous
note
except
overal
even
though
system
detect
virus
tradit
method
filmarray
detect
significantli
virus
mix
infect
xtag
rvp
current
studi
resplex
detect
less
rsv
influenza
type
hmpv
adenoviru
filmarray
increas
rsv
detect
filmarray
also
note
rand
et
al
compar
xtag
rvp
adenovirus
type
studi
reduc
rate
detect
resplex
may
relat
fact
detect
subtyp
b
e
compar
filmarray
detect
subtyp
noteworthi
detect
rate
enteroviru
rhinoviru
invers
relat
two
system
compar
furthermor
filmarray
resplex
enterovirusrhinoviru
ad
togeth
case
would
approxim
equal
total
number
detect
vs
respect
could
result
crossov
detect
relat
differ
nucleic
acid
sequenc
two
assay
rhinovirus
enterovirus
show
extens
genom
similar
yet
differ
phenotyp
characterist
selfcontain
natur
pouch
system
use
filmarray
sampl
prepar
amplif
detect
take
place
close
system
markedli
reduc
risk
carryov
contamin
specimen
resplex
ii
xtag
rvp
requir
extern
nucleic
acid
extract
follow
multiplex
amplif
detect
use
liquidphas
array
technolog
approach
may
carri
risk
carryov
contamin
due
addit
sampl
manipul
lack
close
system
differ
nucleic
acid
extract
prior
amplif
detect
along
variabl
nucleic
acid
sequenc
variat
chemistri
may
also
contribut
differ
test
perform
specimen
collect
procedur
also
contribut
differ
overal
test
perform
molecular
test
use
oropharyng
swab
nasopharyng
swab
nasopharyng
wash
show
multiplex
realtim
rt
pcr
detect
rate
respect
studi
lieberman
et
al
investig
shown
similar
differ
use
differ
swab
collect
procedur
perform
tradit
molecularbas
test
vari
accord
age
group
studi
howev
gener
younger
children
tend
show
higher
viral
load
older
individu
gener
observ
may
account
favor
perform
tradit
molecularbas
test
younger
age
group
present
studi
filmarray
resplex
exhibit
similar
viral
detect
year
age
group
howev
filmarray
outperform
resplex
year
year
group
viral
load
may
lower
year
group
account
overal
increas
sensit
filmarray
materi
cost
molecular
test
greater
dfa
cultur
overal
benefit
may
depend
upon
protocol
involv
could
result
overal
cost
reduct
describ
mahoni
et
al
aspect
cost
analysi
actual
labor
time
involv
filmarray
resplex
current
studi
handsontim
resplex
approxim
h
total
time
h
test
sampl
filmarray
involv
min
handsontim
total
time
hsampl
base
one
cartridg
per
machin
design
filmarray
instrument
throughput
filmarray
integr
relat
number
machin
avail
given
laboratori
laboratori
process
less
one
sampl
per
hour
would
abl
take
advantag
appar
improv
turnaround
time
filmarray
resplex
accommod
larger
specimen
load
would
therefor
take
six
filmarray
instrument
meet
turnaround
time
full
resplex
run
likewis
appar
laborsav
benefit
filmarray
system
appli
primarili
low
volum
set
although
practic
process
time
might
less
state
min
per
sampl
total
handson
time
sampl
might
expect
meet
exceed
resplex
studi
demonstr
promis
autom
broadli
multiplex
pcr
system
detect
viral
respiratori
pathogen
method
combin
exquisit
sensit
molecular
amplif
breath
target
previous
attain
use
culturebas
techniqu
oper
characterist
togeth
increasingli
selfcontain
autom
easytous
method
bring
us
closer
mainstream
adapt
molecular
diagnost
test
longer
limit
academ
center
refer
laboratori
set
widespread
use
power
techniqu
implic
diagnosi
treatment
infect
control
resourc
util
healthcar
set
fund
studi
support
part
american
lebanes
syrian
associ
chariti
alsac
anderson
charit
foundat
reagent
kindli
suppli
qiagen
idaho
technolog
inc
instrument
filmarray
process
provid
idaho
technolog
inc
